Sponsor: Day One Biopharmaceuticals, Inc.

Collaborator: Pacific Pediatric Neuro-Oncology Consortium (PNOC)

Status: Currently enrolling patients

Condition: Low-grade glioma and advanced solid tumors harboring RAF alterations

Phase: 2

NCT Number: NCT04775485

EudraCT Number: 2020-003657-30

Other Study ID Numbers: PNOC026

Discover more details and enrollment information about FIREFLY-1
Interested in learning more?
Click here to contact a member of the Day One Clinical team